BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3859927)

  • 1. High-dose cytosine arabinoside in the initial treatment of acute leukemia.
    Barnett MJ; Waxman JH; Richards MA; Ganesan TS; Bragman KS; Rohatiner AZ; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):133-8. PubMed ID: 3859927
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose cytosine arabinoside in the treatment of childhood malignancies.
    Lie SO; Slørdahl S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):160-5. PubMed ID: 3859931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C
    Nouv Rev Fr Hematol; 1969; 9(2):199-204. PubMed ID: 4239783
    [No Abstract]   [Full Text] [Related]  

  • 5. High dose cytosine arabinoside in the management of refractory acute leukaemia.
    Willemze R; Zwaan FE; Colpin G; Keuning JJ
    Scand J Haematol; 1982 Aug; 29(2):141-6. PubMed ID: 6958004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose cytosine arabinoside: clinical response to therapy in acute leukemia.
    Early AP; Preisler HD; Higby DJ; Brecher M; Browman G; McBride JA
    Med Pediatr Oncol; 1982; 10 Suppl 1():239-50. PubMed ID: 6761568
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemia.
    Greenberg ML; Waxman S
    Eur J Cancer (1965); 1976 Aug; 12(8):617-23. PubMed ID: 1086210
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract]   [Full Text] [Related]  

  • 9. Our experience with cytosine arabinoside in the treatment of acute haemoblastoses.
    Janele J; Rosa L
    Neoplasma; 1973; 20(4):403-11. PubMed ID: 4517058
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytogenetic studies and their clinical correlates in adults with acute leukemia.
    Hart JS; Trujillo JM; Freireich EJ; George SL; Frei E
    Ann Intern Med; 1971 Sep; 75(3):353-60. PubMed ID: 5284907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 12. Central nervous system toxicity of high-dose cytosine arabinoside.
    Barnett MJ; Richards MA; Ganesan TS; Waxman JH; Smith BF; Butler MG; Rohatiner AZ; Slevin ML; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):227-32. PubMed ID: 3925559
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of in vitro growth pattern of colony forming cells in adult acute leukaemia.
    Jehn U; Kern D; Wachholz K; Hölzel D
    Br J Cancer; 1983 Mar; 47(3):423-8. PubMed ID: 6572530
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Peters WG; Willemze R; Colly LP; Colla L
    Br J Haematol; 1985 Apr; 59(4):733-4. PubMed ID: 3857074
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital.
    Keating MJ; Estey E; Plunkett W; Iacoboni S; Walters R; Kantarjian H; Andersson B; Beran M; McCredie KB; Freireich EJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):98-104. PubMed ID: 3859935
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of refractory acute leukaemia with high dose cytosine arabinoside.
    Willemze R; Zwaan FE; Keuning JJ; Colpin G
    Br J Haematol; 1982 Jul; 51(3):497-8. PubMed ID: 6954973
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of acute leukemias in the infancy with cytosine arabinoside].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL
    Minerva Pediatr; 1971 Jun; 23(26):1125-9. PubMed ID: 5286310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytosine arabinoside in the polychemotherapy of acute leukemia].
    Mandelli F
    Minerva Med; 1972 Mar; 63(24):1436-44. PubMed ID: 4502506
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
    Rivera G; Murphy SB; Aur RJ; Verzosa MS; Dahl GV; Mauer AM
    Cancer; 1978 Dec; 42(6):2521-8. PubMed ID: 282003
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with the use of cytosine arabinoside in adult acute leukaemia.
    Brodie GN; Penny R
    Med J Aust; 1970 Mar; 1(13):635-7. PubMed ID: 5267173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.